KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Research & Development (2016 - 2025)

Historic Research & Development for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to $2.7 million.

  • Biolife Solutions' Research & Development rose 4310.62% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 3081.67%. This contributed to the annual value of $7.9 million for FY2024, which is 3446.53% down from last year.
  • As of Q3 2025, Biolife Solutions' Research & Development stood at $2.7 million, which was up 4310.62% from $2.7 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Research & Development high stood at $4.2 million for Q1 2023, and its period low was -$2.0 million during Q4 2022.
  • In the last 5 years, Biolife Solutions' Research & Development had a median value of $2.7 million in 2025 and averaged $2.6 million.
  • Per our database at Business Quant, Biolife Solutions' Research & Development plummeted by 15497.06% in 2022 and then soared by 16627.61% in 2023.
  • Biolife Solutions' Research & Development (Quarter) stood at $3.6 million in 2021, then tumbled by 154.97% to -$2.0 million in 2022, then surged by 166.28% to $1.3 million in 2023, then skyrocketed by 47.19% to $1.9 million in 2024, then skyrocketed by 41.46% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.7 million for Q2 2025, and $2.2 million during Q1 2025.